Artificial sweeteners induce glucose intolerance by altering the gut microbiota

Nature

Volumn 514, Issue 7521, 2014, Pages 181-186

  Suez, Jotham ^a   Korem, Tal ^a   Zeevi, David ^a   Zilberman Schapira, Gili ^a   Thaiss, Christoph A ^a   Maza, Ori ^a   Israeli, David ^b   Zmora, Niv ^c,d   Gilad, Shlomit ^a   Weinberger, Adina ^a   Kuperman, Yael ^a   Harmelin, Alon ^a   Kolodkin Gal, Ilana ^a   Shapiro, Hagit ^a   Halpern, Zamir ^c,d   Segal, Eran ^a   Elinav, Eran ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b Kfar Shaul Hospital   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASPARTAME; DRUG DERIVATIVE; GLUCOSE; SACCHARIN; SUCROSE; SWEETENING AGENT; TRICHLOROSUCROSE;

ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FAT INTAKE; FECES; FEMALE; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; GLUCOSE INTOLERANCE; HUMAN; LIPID DIET; MALE; METABOLIC SYNDROME X; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; WAIST HIP RATIO;

ANIMALS; ANTI-BACTERIAL AGENTS; ASPARTAME; BODY WEIGHT; DIET, HIGH-FAT; DIETARY FATS; FECES; FEMALE; GASTROINTESTINAL TRACT; GERM-FREE LIFE; GLUCOSE; GLUCOSE INTOLERANCE; HUMANS; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICROBIOTA; SACCHARIN; SUCROSE; SWEETENING AGENTS; WAIST-HIP RATIO;

EID: 84908325271     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13793     Document Type: Article

References (40)

1. Gardner, C. et al. Nonnutritive sweeteners: current use and health perspectives. Diabetes Care 35, 1798-1808 (2012).
2. Fitch, C. & Keim, K. S. Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. Journal of the Academy of Nutrition and Dietetics 112, 739-758 (2012).
3. Tordoff, M. G. & Alleva, A. M. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. Am. J. Clin. Nutr. 51, 963-969 (1990).
4. Horwitz, D. L., McLane, M. & Kobe, P. Response to single dose of aspartame or saccharin by NIDDM patients. Diabetes Care 11, 230-234 (1988).
5. Nettleton, J. A. et al. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 32, 688-694 (2009).
6. Roberts, A., Renwick, A. G., Sims, J. & Snodin, D. J. Sucralose metabolism and pharmacokinetics in man. Food Chem. Toxicol. 38 (Suppl. 2), 31-41 (2000).
7. Byard, J. L. & Goldberg, L. The metabolism of saccharin in laboratory animals. Food Cosmet. Toxicol. 11, 391-402 (1973).
8. Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270 (2012).
9. Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184 (2012).
10. Muegge, B. D. et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332, 970-974 (2011).
11. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
12. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006).
13. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
14. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012).
15. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).
16. Peterson, J. et al. The NIH human microbiome project. Genome Res. 19, 2317-2323 (2009).
17. Koropatkin, N. M., Cameron, E. A. & Martens, E. C. How glycan metabolism shapes the human gut microbiota. Nature Rev. Microbiol. 10, 323-335 (2012).
18. Schwiertz, A. et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195 (2010).
19. Bergman, E. N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 70, 567-590 (1990).
20. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
21. Connor, S. C., Hansen, M. K., Corner, A., Smith, R. F. & Ryan, T. E. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol. Biosyst. 6, 909-921 (2010).
22. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
23. Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084-1088 (2013).
24. Sonnenburg, J. L. et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955-1959 (2005).
25. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007).
26. Smith, M. I. et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339, 548-554 (2013).
27. Taylor, J. D., Richards, R. K. & Wiegand, R. G. Toxicological studies with sodium cyclamate and saccharin. Food Cosmet. Toxicol. 6, 313-327 (1968).
28. Goldsmith, L. A. Acute and subchronic toxicity of sucralose. Food Chem. Toxicol. 38 (Suppl. 2), 53-69 (2000).
29. Magnuson, B. A. et al. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol. 37, 629-727 (2007).
30. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7, 335-336 (2010).
31. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
32. DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069-5072 (2006).
33. Blecher-Gonen, R. et al. High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states. Nature Protocols 8, 539-554 (2013).
34. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
35. Marco-Sola, S., Sammeth, M., Guigó, R. & Ribeca, P. The GEM mapper: fast, accurate and versatile alignment by filtration. Nature Methods 9, 1185-1188 (2012).
36. Francis, O. E. et al. Pathoscope: species identification and strain attribution with unassembled sequencing data. Genome Res. 23, 1721-1729 (2013).
37. Kolodkin-Gal, I. et al. D-amino acids trigger biofilm disassembly. Science 328, 627-629 (2010).
38. Shahar, D., Fraser, D., Shai, I. & Vardi, H. Development of a food frequency questionnaire (FFQ) for an elderly population based on a population survey. J. Nutr. 133, 3625-3629 (2003).
39. Shahar, D., Shai, I., Vardi, H., Brener-Azrad, A. & Fraser, D. Development of a semi-quantitative Food Frequency Questionnaire (FFQ) to assess dietary intake of multiethnic populations. Eur. J. Epidemiol. 18, 855-861 (2003).
40. Shai, I. et al. Dietary evaluation and attenuation of relative risk: multiple comparisons between blood and urinary biomarkers, food frequency, and 24-hour recall questionnaires: the DEARR study. J. Nutr. 135, 573-579 (2005).